NCT01218685
- Conditions
- Immunocompromised Patients, Immunogenicity of Pandemic Influenza A (H1N1)Vaccine, Safety of Pandemic Influenza A (H1N1)Vaccine
- Locations
-
- Avenida Vital Brasil 1500 São Paulo, Brazil
Clinical trial condition
Immunogenicity of Pandemic Influenza A (H1N1)Vaccine
Explore clinical trials studying Immunogenicity of Pandemic Influenza A (H1N1)Vaccine. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies